Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study

ConclusionsPatient adherence to pegvisomant was high (60.7 –92.1%), but more than a third of the patients in the study made mistakes during the administration process, with a potential impact on disease control. Besides dosing compliance, correct administration of medication should be carefully assessed in these patients.
Source: Pituitary - Category: Endocrinology Source Type: research